It is my great pleasure to announce that Dr. Amanda Cashen has agreed to serve as Associate Chief for Hematopoietic Malignancies, replacing Dr. Peter Westervelt who is stepping down late this summer after an exceptional term in this position. Amanda first joined the Washington University family over 25 years ago as a medical student. After a residency and hematology-oncology fellowship at Washington University, she joined the faculty in 2006 rising to full professor in 2020. Amanda is an exceptional clinician and a nationally recognized expert in lymphoma and stem cell transplantation, with over 140 publications. She is an experienced clinical trialist, and she currently serves as Executive Chair of the Washington University Institutional Review Board. We are fortunate to have someone of Amanda’s talent to lead the hematopoietic malignancy program in Oncology. Please join me in congratulating Amanda on this new position.